BRIEF-Biomarin Pharmaceutical Reports Q1 Loss Per Share Of $0.25

April 25 (Reuters) - Biomarin Pharmaceutical Inc:

* BIOMARIN ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 REVENUE $373.4 MILLION VERSUS I/B/E/S VIEW $348.7 MILLION

* SEES FY 2018 REVENUE ABOUT $1.5 BILLION

* Q1 EARNINGS PER SHARE VIEW $-0.17 — THOMSON REUTERS I/B/E/S

* AS OF MARCH 31, 2018, BIOMARIN HAD CASH, CASH EQUIVALENTS AND INVESTMENTS TOTALING ABOUT $1.7 BILLION Source text for Eikon: Further company coverage: